Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF (GSLC) seeks to track the Goldman Sachs ActiveBeta U.S. Large Cap Equity Index, which measures the performance of large-capitalization U.S. stocks using a multi-factor approach that weights companies based on quality, value, momentum, and low volatility characteristics rather than market capitalization alone.
How It Works
GSLC employs a rules-based, factor-weighted methodology that combines four investment factors: quality (high return on equity, stable earnings), value (low price-to-book ratios), momentum (positive price trends), and low volatility (reduced price fluctuations). The fund rebalances semi-annually in May and November to maintain factor exposures. Holdings typically include 500-600 large-cap U.S. stocks with sector allocations that can differ significantly from market-cap weighted benchmarks based on factor scores.
Key Features
- Multi-factor approach potentially reduces single-factor risk while targeting outperformance versus traditional market-cap weighted large-cap ETFs
- Goldman Sachs proprietary factor methodology combines academic research with institutional investment experience for systematic stock selection
- Lower turnover than single-factor ETFs due to diversified factor approach, potentially reducing transaction costs and tax implications
Risks
- This ETF can underperform market-cap weighted benchmarks during periods when growth stocks significantly outperform value and quality factors, potentially lagging 5-15% annually
- Factor tilts may concentrate holdings in specific sectors or styles, creating tracking error versus broad market indices during factor rotation periods
- Large-cap U.S. equity exposure means potential 30-40% declines during severe bear markets, with additional volatility from factor-based weighting methodology
Who Should Own This
Best suited as a core equity holding (30-60% of stock allocation) for investors with 5+ year time horizons seeking factor-based outperformance over traditional large-cap exposure. Medium-to-high risk tolerance required due to factor concentration and tracking error. Appropriate for investors who believe multi-factor approaches can generate long-term alpha over market-cap weighting.